- Home
- SMSI vs RLYB Comparison
SMSI vs RLYB Comparison
Compare SMSI & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- RLYB
- Stock Information
- Founded
- SMSI 1982
- RLYB 2018
- Country
- SMSI United States
- RLYB United States
- Employees
- SMSI N/A
- RLYB N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- SMSI Technology
- RLYB Health Care
- Exchange
- SMSI Nasdaq
- RLYB Nasdaq
- Market Cap
- SMSI 15.9M
- RLYB 14.4M
- IPO Year
- SMSI 1995
- RLYB 2021
- Fundamental
- Price
- SMSI $0.90
- RLYB $0.35
- Analyst Decision
- SMSI Strong Buy
- RLYB Hold
- Analyst Count
- SMSI 1
- RLYB 3
- Target Price
- SMSI $5.00
- RLYB $15.00
- AVG Volume (30 Days)
- SMSI 103.7K
- RLYB 329.4K
- Earning Date
- SMSI 07-31-2025
- RLYB 08-07-2025
- Dividend Yield
- SMSI N/A
- RLYB N/A
- EPS Growth
- SMSI N/A
- RLYB N/A
- EPS
- SMSI N/A
- RLYB N/A
- Revenue
- SMSI $19,378,000.00
- RLYB $848,000.00
- Revenue This Year
- SMSI $10.12
- RLYB N/A
- Revenue Next Year
- SMSI $63.12
- RLYB N/A
- P/E Ratio
- SMSI N/A
- RLYB N/A
- Revenue Growth
- SMSI N/A
- RLYB N/A
- 52 Week Low
- SMSI $0.52
- RLYB $0.22
- 52 Week High
- SMSI $2.57
- RLYB $1.54
- Technical
- Relative Strength Index (RSI)
- SMSI 55.29
- RLYB 53.64
- Support Level
- SMSI $0.85
- RLYB $0.30
- Resistance Level
- SMSI $0.98
- RLYB $0.38
- Average True Range (ATR)
- SMSI 0.07
- RLYB 0.04
- MACD
- SMSI 0.01
- RLYB 0.00
- Stochastic Oscillator
- SMSI 69.75
- RLYB 49.29
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.